Oxidized lipid metabolite testing delivers precise, LC-MS/MS-based quantification of oxysterols, isoprostanes, oxidized fatty acids, oxidized phospholipids, and reactive aldehydes in biological, clinical, and food matrices. As validated biomarkers of oxidative stress and lipid peroxidation, these analytes underpin research in cardiovascular disease, neurodegeneration, metabolic disorders, and inflammation, as well as product quality and shelf-life evaluation. Accredited third-party laboratories provide ISO/IEC 17025-aligned analysis using stable isotope dilution, chromatographic separation, and rigorous quality control to ensure reliable, reproducible results.
Technical Overview
Oxidized lipid metabolites are the products of enzymatic and non-enzymatic oxidation of membrane and circulating lipids, including cholesterol, phospholipids, triglycerides, and polyunsaturated fatty acids (PUFAs) such as arachidonic acid, linoleic acid, and docosahexaenoic acid. Free-radical-mediated peroxidation generates hydroperoxides, hydroxy- and keto-derivatives, isoprostanes, oxidized phospholipids, and reactive aldehydes, while enzyme-catalyzed pathways involving cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 monooxygenases produce oxysterols, eicosanoids, epoxy fatty acids, and specialized pro-resolving mediators.
These metabolites are among the most sensitive and widely cited indicators of oxidative stress in vivo. Elevated levels have been linked to atherosclerosis, Alzheimer's and Parkinson's disease, diabetes and metabolic syndrome, non-alcoholic fatty liver disease, chronic inflammation, cancer progression, and aging. Accurate measurement is analytically demanding because oxidized lipid species occur at trace concentrations (pg/mL to low ng/mL), frequently exist as structural or positional isomers, and are highly susceptible to artifactual ex vivo oxidation during sampling and preparation. Professional oxidized lipid metabolite testing therefore combines antioxidant-protected sample handling, chromatographic separation, tandem mass spectrometric detection, and stable isotope dilution quantification.
Testing Samples
Blood Plasma and Serum
Plasma collected in EDTA or heparin tubes is the most common matrix for circulating oxidized lipid markers such as oxysterols, 9- and 13-HODE, F2-isoprostanes, and oxidized LDL. To suppress ex vivo oxidation, blood is typically drawn into pre-chilled tubes containing EDTA (metal chelation) and butylated hydroxytoluene (BHT), processed rapidly at low temperature, and plasma is snap-frozen at −80 °C under nitrogen. Serum is acceptable for some panels but is avoided where clotting-induced eicosanoid generation is a concern.
Urine
Urine is a non-invasive matrix well suited to isoprostane testing, including 15-F2t-isoprostane and its metabolite 2,3-dinor-5,6-dihydro-15-F2t-isoprostane, as well as mercapturic acid conjugates of lipid aldehydes. Both spot (first morning) and 24-hour collections are accepted; results for spot samples are normalized to urinary creatinine measured by an enzymatic or LC-MS-based assay.
Tissue Homogenates
Liver, brain, adipose, heart, vessel wall, and tumor tissues flash-frozen in liquid nitrogen immediately post-excision can be analyzed after homogenization in antioxidant-supplemented buffer. Tissue data are typically normalized to wet weight, protein content, or total lipid content, enabling regional and disease-state comparisons in preclinical studies.
Cerebrospinal Fluid and Other Body Fluids
Cerebrospinal fluid (CSF) is analyzed for neurodegeneration-related oxysterols such as 24S-hydroxycholesterol and 27-hydroxycholesterol, F4-neuroprostanes, and isoprostanes. Other accepted fluids include synovial fluid, bronchoalveolar lavage fluid, amniotic fluid, and breast milk, provided antioxidant protection and cold-chain handling are maintained.
Cell and In Vitro Samples
Cell pellets, conditioned culture media, lipoprotein fractions isolated by ultracentrifugation or fast protein liquid chromatography, and oxidatively stressed model systems are routinely analyzed. Media samples allow monitoring of time- and dose-dependent oxylipin release in pharmacological and mechanistic studies.
Food and Biological Product Matrices
Edible oils, meat and dairy products, infant formula, fish, nuts, and lipid-containing nutraceuticals can be tested for oxidation markers including hydroperoxides, HODEs, MDA, 4-HNE, and volatile aldehydes to support quality control, shelf-life assessment, and compliance evaluation under applicable ISO, GB, and ASTM food-analysis frameworks.
Testing Items
Comprehensive oxidized lipid metabolite panels typically include the following analyte classes, with custom target lists available for targeted projects:
Oxysterols
- 7α-hydroxycholesterol and 7β-hydroxycholesterol
- 7-ketocholesterol and cholestane-3β,5α,6β-triol
- 24S-hydroxycholesterol, 25-hydroxycholesterol, and 27-hydroxycholesterol
- 22R-hydroxycholesterol and 4β-hydroxycholesterol
- 5α,6α- and 5β,6β-epoxycholesterol (cholesterol epoxides)
- 7α-hydroxy-4-cholesten-3-one (C4, a bile acid synthesis marker)
Isoprostanes and Neuroprostanes
- 15-F2t-isoprostane (8-iso-PGF2α) and 8-iso-PGE2
- 8,12-iso-iPF2α-VI
- Urinary metabolite 2,3-dinor-5,6-dihydro-15-F2t-isoprostane
- F3-isoprostanes and F4-neuroprostanes derived from omega-3 fatty acids
- Esterified (phospholipid-bound) isoprostanes after alkaline hydrolysis
Oxidized Fatty Acids and Eicosanoids
- Linoleate products: 9-HODE, 13-HODE, 9-oxoODE, 13-oxoODE, EpOMEs, and DiHOMEs
- HETEs: 5-, 8-, 9-, 11-, 12-, 15-, and 20-HETE; 5-oxoETE
- Epoxyeicosatrienoic acids (EETs) and their dihydroxy metabolites (DHETs)
- Prostaglandins (PGE2, PGD2, PGF2α), thromboxane B2, and 6-keto-PGF1α
- Leukotrienes (LTB4, LTC4, LTD4, LTE4) and lipoxins (LXA4, LXB4)
- Specialized pro-resolving mediators: resolvins (RvD1, RvD2, RvE1), protectin D1, and maresin 1
Reactive Aldehydes and Aldehyde Conjugates
- Malondialdehyde (MDA), free and as thiobarbituric acid or DNPH derivative
- 4-hydroxy-2-nonenal (4-HNE) and 4-oxo-2-nonenal (4-ONE)
- Acrolein and crotonaldehyde
- Short-chain volatile aldehydes (hexanal, heptanal, nonanal)
- Urinary 1,4-dihydroxynonane mercapturic acid (DHN-MA)
Oxidized Phospholipids and Oxidized LDL
- POVPC, PGPC, PazePC, PEIPC, and KOdiAPC (oxidized PAPC species)
- Oxidized phosphatidylethanolamine and phosphatidylserine species
- Lysophosphatidylcholine (16:0, 18:0, 18:1 LPC) and lysophosphatidic acid
- Copper-oxidized LDL (Ox-LDL) and MDA-modified LDL by immunoassay or targeted LC-MS profiling
Testing Methods
Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS)
Targeted LC-MS/MS on triple quadrupole platforms is the reference approach for oxidized lipid metabolite quantification. Ultra-high-performance liquid chromatography with reversed-phase C18 or C30 columns separates positional and geometric isomers, followed by electrospray ionization—negative mode for carboxylated oxylipins and isoprostanes, positive mode for oxysterols and oxidized phospholipids—and multiple reaction monitoring (MRM) of characteristic precursor-to-product transitions. Stable isotope-labeled internal standards (for example, 15-F2t-IsoP-d4, 13-HODE-d4, PGE2-d4, 27-hydroxycholesterol-d7) are spiked before extraction to correct for recovery and matrix effects, achieving limits of detection in the low pg/mL range.
Gas Chromatography–Mass Spectrometry (GC-MS)
GC-MS remains valuable for oxysterol profiling following silylation or nicotinate derivatization, and for isoprostane confirmation after pentafluorobenzyl derivatization with negative-ion chemical ionization, which provides outstanding sensitivity for this analyte class. Fatty acid oxidation products can also be measured as methyl ester or oxo-derivatized species within established ISO- and GB-aligned fatty acid analytical workflows.
Sample Preparation and Ex Vivo Oxidation Control
Total lipids are extracted by modified Folch, Bligh–Dyer, or methyl-tert-butyl ether (MTBE) procedures under cold, low-light conditions with BHT, EDTA, and triphenylphosphine added as required. Mixed-mode anion-exchange or hydrophilic-lipophilic balanced solid-phase extraction (SPE) isolates acidic oxylipins, while silica SPE purifies neutral sterols. Alkaline hydrolysis is applied when total (free plus esterified) isoprostane content is required. Handling protocols strictly limit oxygen exposure, metal contact, freeze–thaw cycles, and processing time, because artifactual oxidation is the principal source of false-positive results.
Derivatization Strategies
- Charge-switch derivatization (for example, AMPP or DMED reagents) to enhance MS sensitivity of carboxylic acid-containing oxylipins
- Picolinic acid or Girard-type hydrazone derivatization of oxysterols to improve ionization and enable isomer discrimination
- DNPH labeling of aldehydes for stable, sensitive HPLC or LC-MS/MS measurement of MDA, HNE, and acrolein
- Trimethylsilylation for GC-MS determination of sterol and HODE species
Screening Immunoassays
Enzyme-linked immunosorbent assays for Ox-LDL, MDA, and 8-iso-PGF2α are available as high-throughput screening options; positive or clinically significant findings are typically confirmed by mass spectrometry because antibody cross-reactivity among eicosanoid isomers can affect specificity.
Quality Assurance and Method Validation
Methods are validated for selectivity, linearity, accuracy, precision, limit of detection, limit of quantification, recovery, matrix effect, carryover, and sample stability in accordance with ISO/IEC 17025 laboratory competence requirements and internationally recognized bioanalytical method validation guidance. Each analytical batch includes calibration curves, isotope-labeled internal standards, matrix blanks, pooled quality-control samples at multiple levels, and replicate assessments. Certified reference materials produced under ISO 17034 are used where available, and medical testing on human specimens can be aligned with ISO 15189 requirements.
Applications
Biomedical and Clinical Research
- Atherosclerosis and cardiovascular risk studies using Ox-LDL, oxysterols, and HODEs
- Neurodegenerative disease research quantifying 24S/27-hydroxycholesterol and F4-neuroprostanes in plasma and CSF
- Diabetes, metabolic syndrome, and NAFLD/NASH studies tracking isoprostanes and oxidized phospholipids
- Inflammation and resolution biology through full eicosanoid and specialized pro-resolving mediator profiling
- Cancer biomarker discovery and oxidative stress monitoring in oncology models
Pharmaceutical and Nutraceutical Development
- Efficacy testing of antioxidant, anti-inflammatory, and lipid-modulating drug candidates
- Preclinical and clinical biomarker endpoints supporting study design and regulatory submissions
- Verification of omega-3, oxylipin-modulating supplement, and functional food claims
- Investigative toxicology assessing drug-induced lipid peroxidation
Food Quality and Industrial Analysis
- Lipid oxidation monitoring in edible oils, fried products, meat, dairy, and seafood
- Shelf-life studies and packaging performance evaluation based on HODE, MDA, and volatile aldehyde markers
- Raw material qualification and oxidation-aligned compliance testing under applicable ISO, ASTM, and GB food standards
- Process optimization for storage, refining, and thermal treatment conditions
FAQ
What are oxidized lipid metabolites and why are they measured?
They are oxidation products of cholesterol, phospholipids, and polyunsaturated fatty acids generated by free radical attack or by COX, LOX, and CYP450 enzymes. Measuring them provides quantitative evidence of oxidative stress and lipid peroxidation, supports disease mechanism research, and evaluates antioxidant interventions.
How can artificial oxidation during sampling be prevented?
Best practice involves pre-chilled anticoagulant tubes with EDTA and BHT, rapid low-temperature processing, protection from light and air, snap-freezing in liquid nitrogen, storage at −80 °C, and shipment on dry ice. These precautions preserve the in vivo oxidation signature and are embedded in professional laboratory protocols.
What sample volumes and storage conditions are required?
Typical requirements are 100–500 µL of plasma or serum, 0.5–2 mL of urine, 50–100 mg of tissue, and 200–500 µL of CSF, depending on the panel breadth. Samples should be stored at −80 °C with no more than one freeze–thaw cycle before analysis.
Can both free and esterified (lipid-bound) metabolites be quantified?
Yes. Free oxylipins are measured by direct extraction, while total levels are obtained after alkaline or enzymatic hydrolysis of esterified species. Comparing free, esterified, and total pools reveals the distribution of oxidized lipids between circulating lipoproteins and cell membranes.
What is the difference between targeted and untargeted oxidized lipidomics?
Targeted analysis uses authentic standards and MRM transitions for absolute quantification of a defined analyte list with the highest sensitivity and rigor. Untargeted or semi-targeted high-resolution mass spectrometry (LC-HRMS) enables discovery of novel oxidized lipid species, which can subsequently be incorporated into validated targeted panels.
How are results reported?
Reports provide concentrations with units (ng/mL, pg/mL, ng/g, or ng/mg creatinine), calibration and QC performance, method validation summaries, limits of quantification, and interpretation guidance. Studies comparing disease and control groups can additionally receive statistical summaries of group differences.
What is the typical turnaround time?
Standard targeted panels are generally completed within 10–15 working days after sample receipt, while large-cohort studies, custom panel development, and untargeted discovery workflows may require additional method development and data processing time.
